A model to study total hepatic ischemia-reperfusion injury

被引:24
|
作者
Kanoria, S
Glantzounis, G
Jalan, R
Davies, NA
Seifalian, AM
Williams, R
Davidson, BR
机构
[1] Royal Free Hosp, Acad Dept Surg, Hepatobiliary & Liver Transplant Unit, London NW3 2QG, England
[2] UCL Hosp, Inst Hepatol, London W1N 8AA, England
[3] UCL, Sch Med, London W1N 8AA, England
关键词
D O I
10.1016/j.transproceed.2004.10.031
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Most experimental animal models for studying hepatic ischemia-reperfusion injury (IRI) involve partial or segmental ischemia of the liver or a portocaval shunt procedure to avoid mesenteric congestion. However, these do not reflect the global ischemia that occurs during liver transplantation. A rabbit model of total hepatic ischemia without a portocaval shunt is described. Methods. Twenty male New Zealand white rabbits (3.5 +/- 0.3 kg) were allocated to four groups: group 1 (n = 5), sham-operated; group 2 (n = 5), 20-minute total hepatic ischemia; group 3 (n = 5), 25-minute total hepatic ischemia; and group 4 (n = 5), 30-minute total hepatic ischemia. Total hepatic ischemia was induced by occluding the portal inflow vessels (portal vein and artery) with an atraumatic vascular loop and were measurements taken for 2 hours during reperfusion. Results. A total hepatic ischemia of 30 minutes caused severe liver injury resulting in cardiac arrest at 2 hours of reperfusion in all five animals due to metabolic acidosis. Twenty minutes of total ischemia was tolerated and did not produce significant liver injury. Twenty-five minutes of total ischemia was tolerated but at 2 hours of reperfusion, resulted in significant liver injury (68 +/- 41, 283.0 +/- 20.5, and 835.2 +/- 52.7 U/L) compared with the sham-operated group (serum ALT, 25.4 +/- 2.7; serum AST, 47.4 +/- 3.0; serum LDH, 307.6 +/- 44.4 U/L; P < .003). Conclusions. Rabbits can tolerate 25 minutes of total hepatic ischemia without a portosystemic shunt. This 25-minute ischemia model simulates operative conditions during liver transplantation and will be valuable in studies modulating IRI.
引用
收藏
页码:2586 / 2589
页数:4
相关论文
共 50 条
  • [41] Hepatic Ischemia-reperfusion Injury: Protective Approaches and Treatment
    Singh, Kuldeep
    Gupta, Jeetendra Kumar
    Kuma, Shivendra
    Anurag
    Mukherjee, Soumyadip
    Patel, Aman
    CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [42] Oxytocin alleviates hepatic ischemia-reperfusion injury in rats
    Dusunceli, Fikret
    Iseri, Sevgin Oe.
    Ercan, Feriha
    Gedik, Nursal
    Yegen, Cumhur
    Yegen, Berrak C.
    PEPTIDES, 2008, 29 (07) : 1216 - 1222
  • [43] The influence of organ temperature on hepatic ischemia-reperfusion injury
    Biberthaler, P
    Luchting, B
    Massberg, S
    Teupser, D
    Langer, S
    Leiderer, R
    Messmer, K
    Krombach, F
    TRANSPLANTATION, 2001, 72 (09) : 1486 - 1490
  • [44] Mitochondrial quality control in hepatic ischemia-reperfusion injury
    Wang, LiuSong
    Feng, Zan Jie
    Ma, Xuan
    Li, Kai
    Li, Xin Yao
    Tang, Yi
    Peng, Cijun
    HELIYON, 2023, 9 (07)
  • [45] Role of nitric oxide in hepatic ischemia-reperfusion injury
    Siriussawakul, Arunotai
    Zaky, Ahmed
    Lang, John D.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (48) : 6079 - 6086
  • [46] Effects of amrinone on hepatic ischemia-reperfusion injury in rats
    Kobayashi, T
    Sugawara, Y
    Ohkubo, T
    Imamura, H
    Makuuchi, M
    JOURNAL OF HEPATOLOGY, 2002, 37 (01) : 31 - 38
  • [47] Ischemic preconditioning:: tolerance to hepatic ischemia-reperfusion injury
    Serafín, A
    Fernández-Zabalegui, L
    Prats, N
    Wu, ZY
    Roselló-Catafau, J
    Peralta, C
    HISTOLOGY AND HISTOPATHOLOGY, 2004, 19 (01) : 281 - 289
  • [48] BIOCHEMICAL APPRAISAL OF MODELS FOR HEPATIC ISCHEMIA-REPERFUSION INJURY
    CANADA, AT
    STEIN, K
    MARTEL, D
    WATKINS, WD
    CIRCULATORY SHOCK, 1992, 36 (03) : 163 - 168
  • [49] MicroRNAs: Novel Targets in Hepatic Ischemia-Reperfusion Injury
    Ingram, Holly
    Dogan, Murat
    Eason, James D.
    Kuscu, Cem
    Kuscu, Canan
    BIOMEDICINES, 2022, 10 (04)
  • [50] Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury
    Huang, Miao
    Cai, Hao
    Han, Bing
    Xia, Yuhan
    Kong, Xiaoni
    Gu, Jinyang
    FRONTIERS IN IMMUNOLOGY, 2022, 13